Skip to main content

myo-Inositol/(Creatine and Phosphocreatine) ratio


Basic information
Metabolite name

myo-Inositol/(Creatine and Phosphocreatine) ratio

N/A
N/A
N/A
Synonyms

Myo-ionisitol/(Creatine and Phosphocreatine) ratio;
Myo-inositol/(Creatine and Phosphocreatine) ratios

No. of studies

28

 

Relationship between myo-Inositol/(Creatine and Phosphocreatine) ratio and depression (count: 28)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M225 Type1 depression group vs. control group Dorsolateral white matter Human Up
Study M228 Type1 depression group vs. control group Frontal lobe Human Down
Study M245 Type1 depression group vs. control group Anterior cingulate cortex/Prefrontal cortex Human Down
Study M255 Type1 depression group vs. control group Anterior cingulate cortex Human Up
Study M259 Type1 depression group vs. control group Hippocampus Human Up
Study M259 Type1 depression group vs. control group Frontal lobe Human Up
Study M259 Type2 SSRI-treated depression group post-treatment vs. pre-treatment Frontal lobe Human Down
Study M265 Type1 unmedicated depression group vs. control group Basal ganglia Human Up
Study M267 Type2 SSRI-treated depression group post-treatment vs. pre-treatment Dorsolateral prefrontal cortex Human Up
Study M271 Type1 depression group vs. control group Thalamus Human Down
Study M271 Type1 depression group vs. control group Hypothalamus Human Down
Study M276 Type3 FST + DMI group vs. FST group Dorsolateral prefrontal cortex Sprague-Dawley rat Down
Study M279 Type1 depression group vs. control group Prefrontal cortex Human Down
Study M279 Type2 rTMS-treated responder group post-treatment vs. pre-treatment Prefrontal cortex Human Up
Study M281 Type1 depression group vs. control group Frontal lobe Human Up
Study M289 Type1 recurrent depression group vs. control group Prefrontal cortex Human Up
Study M289 Type1 first-episode depression group vs. control group Prefrontal cortex Human Up
Study M294 Type1 CMS group vs. control group Hippocampus Sprague-Dawley rat Up
Study M306 Type1 depression group vs. control group Hippocampus Human Up
Study M309 Type1 hypobaric hypoxia group vs. control group Frontal cortex Sprague-Dawley rat Up
Study M315 Type1 AD with depression group vs. AD without depression group Anterior cingulate gyrus Human Up
Study M318 Type1 migraine with depression group vs. migraine without depression group Dorsolateral prefrontal cortex Human Up
Study M319 Type1 depression group vs. control group Hippocampus Human Up
Study M326 Type1 depression group vs. control group Insula Human Down
Study M326 Type2 MBCT-treated depression group post-treatment vs. pre-treatment Caudate Human Down
Study M334 Type1 depression group vs. control group Dorsal prefrontal cortex Human Up
Study M338 Type1 control group vs. sham group Hippocampus Wistar rat Up
Study M338 Type2 EPA + E group vs. EPA group Hippocampus Wistar rat Down
Study M338 Type2 ALA + E group vs. ALA group Hippocampus Wistar rat Down
Study M338 Type2 DHA + E group vs. DHA group Hippocampus Wistar rat Down
Study M338 Type2 NC + E group vs. NC group Hippocampus Wistar rat Down
Study M343 Type1 severe depression group vs. control group Thalamus Human Up
Study M343 Type1 moderate depression group vs. control group Thalamus Human Up
Study M345 Type1 depression group vs. control group Anterior cingulate cortex Human Down
Study M491 Type1 post-CFSS vs. pre-CFSS Prefrontal cortex Wistar rat Up
Study M521 Type1 CUMS group vs. control group Hippocampus Wistar rat Up
Study M733 Type3 fluoxetine group vs. control group, day 1 Medial prefrontal cortex Sprague-Dawley rat Down
Study M752 Type1 PSD group vs. control group Hippocampus Wistar rat Up
Study M752 Type1 PSD group vs. control group Prefrontal cortex Wistar rat Up
Study M752 Type2 PSD + Yi-nao-jie-yu decoction group vs. PSD group Hippocampus Wistar rat Down
Study M944 Type1 MDD group vs. control group Anterior midcingulate cortex Human Up